WHO Recommends Two New Ebola Vaccine Candidates for Clinical Trials in DRC

The World Health Organization (WHO) has recommended the inclusion of two new vaccine candidates, ChAdOx1 BDBV (developed by the University of Oxford with the Serum Institute of India) and Moderna's mRNA-1469, in ongoing clinical trials in the Democratic Republic of the Congo (DRC). This initiative aims to combat an Ebola outbreak caused by the Bundibugyo virus.